Providers

Willkie has extensive experience in the health care and life sciences field, both in the United States and abroad. We represent companies and investors in the areas of biotechnology, pharmaceuticals, medical technology, wellness and providers. Our work includes corporate transactions, mergers and acquisitions, joint venture transactions, compliance matters, IP issues, patent litigation and counseling, and general litigation.

Willkie has extensive experience in the health care and life sciences field, both in the United States and abroad. We represent companies and investors in the areas of biotechnology, pharmaceuticals, medical technology, wellness and providers. Our work includes corporate transactions, mergers and acquisitions, joint venture transactions, compliance matters, IP issues and general litigation.

Business Reorganization and Restructuring

  • Medical Resources, Inc.: Represented Medical Resources, an operator of diagnostic imaging centers primarily in the northeastern U.S., in its chapter 11 and restructuring case.

    Texas Health Resources (THR): Represented creditor Warburg Pincus in the chapter 11 case of THR.

- Collapse

Capital Markets

  • Brookdale Senior Living Inc.: Represented the underwriters, led by BofA Merrill Lynch and Goldman, Sachs & Co as the joint book-running managers and CSCA Capital Advisors, LLC and RBC Capital Markets as the co-managers in Brookdale’s $300 million offering of common stock. We also represented Morgan Stanley & Co. LLC in Brookdale’s $621 million secondary offering.

    Connectmed.com: Advised Connectmed, a provider of direct medical and interactive telemedical care for underserved areas, on multiple rounds of financing.

    Health Equity, Inc.: Represented Health Equity, Inc., one of the largest U.S. Health Savings Account non-bank custodians, in its initial public offering and follow-on offerings.

    Ventas, Inc.: Represented Ventas, the leading senior housing and healthcare REIT in the United States, in numerous offerings and related transactions, including:
    • $700 million offering of senior notes.
    • $850 million offering of senior notes.
    • $925 million offering of senior notes.
    • $1.13 billion secondary offering of Ventas common stock by Lazard Real Estate Partners.
    • $275 million offering of senior notes.
    • $600 million offering of senior notes.
- Collapse

Corporate Matters

  • Pharmaceutical Marketing Services, Inc. (PMSI): Provided PMSI, a provider of information and market research services to pharmaceutical and healthcare companies in the United States, with general corporate and board representation for various matters.

    Schein Pharmaceuticals, Inc.: Represented founding family members in connection with the reorganization of Schein Pharmaceuticals, Inc., the spin-off of Henry Schein, Inc. (the largest distributor of healthcare products and services to office-based medical and dental practitioners, laboratories and veterinary clinics, and related institutions), and in connection with stock sales and governance matters.

- Collapse

Mergers & Acquisitions, PE & VC Investments, Joint Ventures and Other Business Combinations

  • Calvert Street Capital Partners/Lagniappe Health Systems: Represented Calvert Street in its acquisition of Lagniappe Health Systems.

    CapStreet Group/ Keais Records Service, LLC:  Represented CapStreet Group in its acquisition of a majority stake in Keais Records Service, LLC, a leading medical records processor.

    Centerbridge Partners/Superior Vision: Represented Centerbridge Partners in its acquisition of Superior Vision Corporation, a leader in managed vision care, from Nautic Partners.

    Electra Investment Trust plc/Capitol Health Partners: Represented Electra in connection with its private equity investment in Capitol Health Partners.

    HealthcareSource/Francisco Partners/Insight Venture Partners: Represented HealthcareSource, the leading provider of talent management solutions for the healthcare industry, in its agreement to be acquired by private equity firm Francisco Partners. Insight Venture Partners was the majority owner of HealthcareSource.

    Insight Venture Partners/Kinnser Software: Advised Insight on its $40 million investment in Kinnser, a Web-based software solutions provider.

    MedAssets, Inc.: Advised this provider of healthcare supply chain management and revenue cycle management services on its acquisition-related transactions with the following companies:

    • Pamplona Capital Management: Advised MedAssets on its agreement to be acquired by Pamplona Capital Management for $2.7 billion.
    • SG-2, LLC: Represented MedAssets on its $142 million acquisition of healthcare market intelligence and strategic analytics platform, Sg2.

    PAI Partners/DomusVi: Represented PAI Partners in its acquisition of a majority stake in DomusVi, a leading French retirement and nursing home company.

    PAI Partners/DomusVi/SARquavitae: Represented PAI Partners and its portfolio company DomusVi in the pending acquisition of SARquavitae, one of the leaders of elderly care services in Spain, valuing the company at approximately €440 million on an enterprise basis.

    Quantum Strategic Partners/Oak Street Health: Represented Quantum Strategic Partners in its minority investment in Oak Street Health, operator of primary care centers focused on seniors in the Chicago metropolitan area. 

    RegionalCare: Represented Warburg Pincus portfolio company RegionalCare Hospital Partners, an owner and operator of regional acute care facilities, in its agreement to be acquired by Apollo.

    SenioCare/Waterland Private Equity: Advised Waterland Private Equity on the acquisition of SenioCare.

    UBS Securities/Ramsey Health Care: Represented UBS Securities in the sale of Ramsey, an international hospital group.

    Warburg Pincus/Alignment Healthcare Partners: Represented Warburg Pincus in its $115 million investment in Alignment Healthcare Partners, LP.

    Warburg Pincus/ComplexCare Solutions: Represented Warburg Pincus in its $40 million investment in ComplexCare Solutions, Inc., a health services company.

- Collapse

Other Significant Matters

  • ELZ Sağlık Yatırım A.Ş.: Represented project sponsor and borrower ELZ Sağlık Yatırım A.Ş. and its shareholders in the Elazıg Integrated Health Campus Project, a public-private partnership (PPP) in Turkey providing for the design, construction, equipment, financing of the health campus, comprising an 888-bed main hospital, 150-bed high-security forensic psychiatric hospital, and 60-unit oral and dental clinic.

    HealthSouth Corporation: Participated in investigations or inquiries into potential accounting issues and financial reporting matters at Healthsouth.

    Meridiam and Ronesans: Represented Meridiam and Ronesans as the main sponsors of the first healthcare PPP project in Turkey. The  €550 million project will create a major healthcare facility in Turkey’s fifth largest city,  The 250,000 square meters facility will include a general hospital, an oncology hospital,  a cardiovascular hospital , a women and children's hospital, a physical medicine and rehabilitation hospital, and a forensic psychiatric hospital.

    NDC Health: Advised NDC on “one-stop shopping” bank/bond acquisition and recapitalization financing for NDC, an Atlanta, Georgia-based provider of electronic health information processing services for pharmacies, physicians and hospitals.

    Sponsors (including Meridiam, Rönesans, Sila Group, and Sam Yapi): Represented the sponsors and the project company in the second healthcare public-private partnership (PPP) in Turkey, which provides for the design, financing, construction, operation and maintenance of a new 476-bed hospital in Yozgat, Turkey.

- Collapse